Metabolic Research: Type 2 Diabetes Clinical Trial & Obesity

Empathx’ mix of dedicated and embedded research sites provides the optimal blend of locations under a single partnership, leveraging known patients and existing provider:patient relationships, enhancing willingness to participate to the forefront of cardio-metabolic research. 

Trust Empathx for direct access to specialty patient populations with renal and hepatic impairment actively receiving treatment from our experienced investigators.  

Empathx conducted more than 100 metabolic disorder studies, including deep experience with varying liver biopsy sample preparation types (i.e. flash-frozen) spanning MASH, MAFLD, Diabetes, and Obesity, often in predominantly minority patients. 

We Are Proud to Have Partnered With

89bio
altimmune
AstraZeneca
biomea fusion
Boehringer Engelheim
gsk GlaxoSmithKline
Hanmi
Lilly
Madrigal Pharmaceuticals
NeuroBo Pharmaceuticals
Novo Nordisk
Rivus Pharmaceuticals
Shionogi
Viking Pharma

Our Research Areas

  • Type 2 Diabetes Clinical Trials

  • MASH

  • MASLD

  • Obesity

  • Hypertension

Eliminate Traditional Site Management Bottlenecks

Local Rapport. Central Support. Maximized Trial Equity.

Empathx delivers strategic solutions for clinical trials through abiding compassion, innovative technology, and deep-rooted partnerships.

Get Started